latest news releases from the newsroom
KLIPPAN AB -- Guarantee For New Share Issue
KLIPPAN, Sweden, Sept. 12, 2005 (PRIMEZONE) -- Nordea Bank and Weland AB are guaranteeing the new share issue for KLIPPAN AB, each with 50 percent, up to MSEK 161.2. The guarantee is conditional upon the settlement proposals made by the Board of 37 percent being approved by the District Courts in Helsingborg and Malmo. The share issue with issue conditions will be decided upon once a settlement has been approved.
Labaton Sucharow LLP
Investor Deadline: September 26, 2005, is the Last Day to Join Shareholder Class Action Against RenaissanceRe Holdings Ltd. as a Potential Lead Plaintiff -- RNR
NEW YORK, Sept. 12, 2005 (PRIMEZONE) -- Goodkind Labaton Rudoff & Sucharow LLP filed a class action lawsuit on July 27, 2005, in the United States District Court for the Southern District of New York on behalf of persons who purchased or otherwise acquired publicly traded securities of RenaissanceRe Holdings Ltd. ("RenaissanceRe" or the "Company") (NYSE:RNR) between January 24, 2002, and July 25, 2005, inclusive, (the "Class Period"). The lawsuit was filed against RenaissanceRe, James Standard, Michael W. Cash, William Riker, John M. Lummis and Martin J. Merritt ("Defendants"). The deadline to move for Lead Plaintiff is September 26, 2005.
Cytomedix Announces Preliminary Results of Clinical Trial for Treatment of Diabetic Foot Ulcers
ROCKVILLE, Md., Sept. 12, 2005 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced that preliminary analysis of a clinical trial for its AutoloGel(tm) platelet gel therapy system for the treatment of diabetic foot ulcers is underway. Early analysis appears to indicate that for total wound closure as the clinical end-point, the clinical efficacy of this product may be approximately similar to the standard therapy that was used as a control in the clinical trial. No product-related significant adverse effects were observed in the study.